Search

Leesa M Barone

from Winthrop, MA
Age ~67
Get Report
Also known as:
Leesa Dr Barone, Lessa M Barone, Barone Lessa
Phone and address:
131 Court Rd, Winthrop Hlds, MA 02152
(617) 539-0961
Related to:
Brad A Barone, 55
Connected to:
Alexandria Barone, 35Amy Barone, 50Anthony Barone, 70Armanda R Barone, 67Biagio W Barone, 77Bryan D Barone, 45Carmine R Barone, 56Carole A Barone, 82Caroline L Barone, 101Casper L Barone, 84

Leesa Barone Phones & Addresses

  • 131 Court Rd, Winthrop, MA 02152 (617) 539-0961
  • 212 Lincoln St, Winthrop, MA 02152 (617) 539-0961
  • 35 Moore St #3, Winthrop, MA 02152 (617) 856-4953
  • 185 Stimson St, West Roxbury, MA 02132 (617) 539-0961
  • 3 Dunning Way, Jamaica Plain, MA 02130 (617) 983-4949
  • 3 Dunning Way #98F, Jamaica Plain, MA 02130
  • Fitchburg, MA
  • Boerne, TX
  • Somerville, MA
  • 131 Court Rd, Winthrop, MA 02152 (617) 680-0473

Work

Position: Sales Occupations

Education

Degree: Associate degree or higher

Emails

l***[email protected]

Resumes

Resumes

Leesa Barone Photo 1

Senior Medical Liaison

View page
Location:
Boston, MA
Industry:
Mental Health Care
Work:
Sunovion Pharmaceuticals Inc.
Senior Medical Liaison
Leesa Barone Photo 2

Senior Medical Science Liaison, Urology

View page
Location:
131 Court Rd, Winthrop, MA 02152
Industry:
Pharmaceuticals
Work:
Urovant Sciences
Senior Medical Science Liaison, Urology
Milestone Pharmaceuticals, Inc.
Medical Science Liaison, Cardiology
Mallinckrodt Pharmaceuticals 2014 - Nov 2018
Principal Medical Science Liaison, Pulmonology, Rheumatology, Ophthalmology
Auxilium Pharmaceuticals 2012 - 2014
Regional Medical Scientist, Orthopedics and Urology
Intermune 2010 - 2012
Medical Science Director, Respiratory
Education:
Boston University School of Medicine
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy Smith College
Bachelors, Biochemistry
Skills:
Science
Liaison
Medicine
Leesa Barone Photo 3

Leesa Barone

View page
Location:
Boston, MA
Work:
Mallinckrodt Pharmaceuticals
Principal Medical Science Liaison, Pulmonology
Leesa Barone Photo 4

Senior Medical Liaison At Sepracor

View page
Position:
Senior Medical Liaison at Sepracor
Location:
Greater Boston Area
Industry:
Mental Health Care
Work:
Sepracor
Senior Medical Liaison
Education:
PhD

Publications

Us Patents

Methods And Compositions For The Repair Of Articular Cartilage Defects In Mammals

View page
US Patent:
57862176, Jul 28, 1998
Filed:
Apr 14, 1997
Appl. No.:
8/834150
Inventors:
Ross A. Tubo - Quincy MA
Leesa M. Barone - Winthrop MA
Courtney A. Wrenn - Haverhill MA
Assignee:
Genzyme Corporation - Framingham MA
International Classification:
C12N 500
US Classification:
435402
Abstract:
Provided are methods and compositions for the repair of articular cartilage defects in a mammal. Denuded chondrogenic cells are proliferated ex vivo as monolayer cultures in order to expand the pool of available chondrogenic cells. During proliferation the chondrogenic cells stop secreting the extracellular matrix components, type II collagen and sulfated proteoglycans. The proliferated cells then are seeded into a pre-shaped well having a cell contacting, cell abhesive surface. The cells cultured in the well redifferentiate and begin to secrete cartilage-specific extracellular matrix again. Accordingly, essentially unlimited amounts of synthetic cartilage may be prepared from small samples of biopsy tissue. Also provided are methods for surgically repairing articular cartilage defects in mammals using the synthetic cartilage prepared in accordance with the invention.

Methods And Compositions For The Repair Of Articular Cartilage Defects In Mammals

View page
US Patent:
57233314, Mar 3, 1998
Filed:
Jun 6, 1995
Appl. No.:
8/469966
Inventors:
Ross A. Tubo - Quincy MA
Leesa M. Barone - Winthrop MA
Courtney A. Wrenn - Haverhill MA
Assignee:
Genzyme Corporation - Framingham MA
International Classification:
C12N 500
C12N 502
US Classification:
435366
Abstract:
Provided are methods and compositions for the repair of articular cartilage defects in a mammal. Denuded chondrogenic cells are proliferated ex vivo as monolayer cultures in order to expand the pool of available chondrogenic cells. During proliferation the chondrogenic cells stop secreting the extracellular matrix components, type II collagen and sulfated proteoglycans. The proliferated cells then are seeded into a pre-shaped well having a cell contacting, cell abhesive surface. The cells cultured in the well redifferentiate and begin to secrete cartilage-specific extracellular matrix again. Accordingly, essentially unlimited amounts of synthetic cartilage may be prepared from small samples of biopsy tissue. Also provided are methods for surgically repairing articular cartilage defects in mammals using the synthetic cartilage prepared in accordance with the invention.
Control profile
Leesa M Barone from Winthrop, MA, age ~67 Get Report